Skip to main content
Top
Published in: Cough 1/2007

Open Access 01-12-2007 | Short report

Prevalence and clinical manifestations of gastro-oesophageal reflux-associated chronic cough in the Japanese population

Authors: Hisako Matsumoto, Akio Niimi, Masaya Takemura, Tetsuya Ueda, Masafumi Yamaguchi, Hirofumi Matsuoka, Makiko Jinnai, Kazuo Chin, Michiaki Mishima

Published in: Cough | Issue 1/2007

Login to get access

Abstract

Gastro-oesophageal reflux (GOR) is one of the most common causes of chronic cough in Western countries, responsible for 10 to 40% of cases. In Japan, however, GOR-associated chronic cough (GOR-CC) has been rarely reported and its clinical manifestation including frequency of concomitant reflux laryngitis is poorly known.
We have analyzed prevalence and clinical characteristics of patients who were diagnosed as having GOR-CC among adult patients with chronic cough (≥ 8 weeks) who visited our asthma and cough clinic over a period of 19 months. Diagnosis of GOR-CC was based on the response of coughing to a proton-pump inhibitor (lansoprazole™) and/or positive results of 24 h ambulatory esophageal pH monitoring. Laryngeal involvement was based on symptoms or objective diagnosis by specialists.
GOR-associated chronic cough was diagnosed in 7.1% (8 of 112) of chronic cough patients. In addition to the demographic data which were consistent with the characteristics of patients with GOR-CC in the Western populations, including gender (6 females), age (mean ± SE, 56.9 ± 5.8 years), duration of cough (9.9 ± 3.3 months), lack of gastrointestinal symptoms (3 of 8) and complication with other causes of cough (5 of 8), we found the standard range of body mass index (23.9 ± 1.5 kg/m2) and high incidence of concomitant reflux laryngitis (5 of 8) in the present 8 patients. Among 4 patients who could stop treatment with temporal resolution of cough, cough recurred in 3 patients, 1 week to 8 months after the discontinuation.
In conclusion, GOR-CC is a less frequent cause of chronic cough in Japan than in Western countries. Signs or symptoms of laryngitis may be important as clues to suspicion of GOR-CC.
Literature
2.
go back to reference Irwin RS: Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines. Chest. 2006, 129 (1 Suppl): 80S-94S. 10.1378/chest.129.1_suppl.80S.CrossRefPubMed Irwin RS: Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines. Chest. 2006, 129 (1 Suppl): 80S-94S. 10.1378/chest.129.1_suppl.80S.CrossRefPubMed
3.
go back to reference Matsumoto H, Niimi A, Satou S, Kishi K: [Chronic cough caused by gastroesophageal reflux]. Nihon Kokyuki Gakkai Zasshi. 2000, 38 (6): 461-465.PubMed Matsumoto H, Niimi A, Satou S, Kishi K: [Chronic cough caused by gastroesophageal reflux]. Nihon Kokyuki Gakkai Zasshi. 2000, 38 (6): 461-465.PubMed
4.
go back to reference McGarvey LP, Heaney LG, Lawson JT, Johnston BT, Scally CM, Ennis M, Shepherd DR, MacMahon J: Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol. Thorax. 1998, 53 (9): 738-743.PubMedCentralCrossRefPubMed McGarvey LP, Heaney LG, Lawson JT, Johnston BT, Scally CM, Ennis M, Shepherd DR, MacMahon J: Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol. Thorax. 1998, 53 (9): 738-743.PubMedCentralCrossRefPubMed
5.
go back to reference Niimi A, Amitani R, Suzuki K, Tanaka E, Murayama T, Kuze F: Eosinophilic inflammation in cough variant asthma. Eur Respir J. 1998, 11 (5): 1064-1069. 10.1183/09031936.98.11051064.CrossRefPubMed Niimi A, Amitani R, Suzuki K, Tanaka E, Murayama T, Kuze F: Eosinophilic inflammation in cough variant asthma. Eur Respir J. 1998, 11 (5): 1064-1069. 10.1183/09031936.98.11051064.CrossRefPubMed
6.
go back to reference The committee for The Japanese Respiratory Society guidelines for management of cough: Prolonged and chronic cough. Respirology. 2006, 11: S160-S174. 10.1111/j.1440-1843.2006.00920_8.x.CrossRef The committee for The Japanese Respiratory Society guidelines for management of cough: Prolonged and chronic cough. Respirology. 2006, 11: S160-S174. 10.1111/j.1440-1843.2006.00920_8.x.CrossRef
7.
go back to reference Niimi A: Geography and cough aetiology. Pulmonary Pharmacology & Therapeutics. Niimi A: Geography and cough aetiology. Pulmonary Pharmacology & Therapeutics.
8.
go back to reference Fujimura M, Mizuguchi M, Nakatsumi Y, Mizuhashi K, Sasaki S, Yasui M: Addition of a 2-month low-dose course of levofloxacin to long-term erythromycin therapy in sinobronchial syndrome. Respirology. 2002, 7 (4): 317-324. 10.1046/j.1440-1843.2002.t01-1-00405.x.CrossRefPubMed Fujimura M, Mizuguchi M, Nakatsumi Y, Mizuhashi K, Sasaki S, Yasui M: Addition of a 2-month low-dose course of levofloxacin to long-term erythromycin therapy in sinobronchial syndrome. Respirology. 2002, 7 (4): 317-324. 10.1046/j.1440-1843.2002.t01-1-00405.x.CrossRefPubMed
9.
go back to reference Fujimura M, Ogawa H, Nishizawa Y, Nishi K: Comparison of atopic cough with cough variant asthma: is atopic cough a precursor of asthma?. Thorax. 2003, 58 (1): 14-18. 10.1136/thorax.58.1.14.PubMedCentralCrossRefPubMed Fujimura M, Ogawa H, Nishizawa Y, Nishi K: Comparison of atopic cough with cough variant asthma: is atopic cough a precursor of asthma?. Thorax. 2003, 58 (1): 14-18. 10.1136/thorax.58.1.14.PubMedCentralCrossRefPubMed
10.
go back to reference WHO::Global Database on Body Mass Index: [www.who.int/bmi/index.jsp]. WHO::Global Database on Body Mass Index: [www.who.int/bmi/index.jsp].
11.
go back to reference Furukawa N, Iwakiri R, Koyama T, Okamoto K, Yoshida T, Kashiwagi Y, Ohyama T, Noda T, Sakata H, Fujimoto K: Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy. J Gastroenterol. 1999, 34 (4): 441-444. 10.1007/s005350050293.CrossRefPubMed Furukawa N, Iwakiri R, Koyama T, Okamoto K, Yoshida T, Kashiwagi Y, Ohyama T, Noda T, Sakata H, Fujimoto K: Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy. J Gastroenterol. 1999, 34 (4): 441-444. 10.1007/s005350050293.CrossRefPubMed
12.
go back to reference Mishima I, Adachi K, Arima N, Amano K, Takashima T, Moritani M, Furuta K, Kinoshita Y: Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol. 2005, 40 (9): 1005-1009. 10.1080/00365520510023260.CrossRefPubMed Mishima I, Adachi K, Arima N, Amano K, Takashima T, Moritani M, Furuta K, Kinoshita Y: Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol. 2005, 40 (9): 1005-1009. 10.1080/00365520510023260.CrossRefPubMed
13.
go back to reference Heading RC: Prevalence of upper gastrointestinal symptoms in the general population: a systematic review. Scand J Gastroenterol Suppl. 1999, 231: 3-8.PubMed Heading RC: Prevalence of upper gastrointestinal symptoms in the general population: a systematic review. Scand J Gastroenterol Suppl. 1999, 231: 3-8.PubMed
14.
go back to reference Jaspersen D, Kulig M, Labenz J, Leodolter A, Lind T, Meyer-Sabellek W, Vieth M, Willich SN, Lindner D, Stolte M, Malfertheiner P: Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther. 2003, 17 (12): 1515-1520. 10.1046/j.1365-2036.2003.01606.x.CrossRefPubMed Jaspersen D, Kulig M, Labenz J, Leodolter A, Lind T, Meyer-Sabellek W, Vieth M, Willich SN, Lindner D, Stolte M, Malfertheiner P: Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther. 2003, 17 (12): 1515-1520. 10.1046/j.1365-2036.2003.01606.x.CrossRefPubMed
15.
go back to reference Irwin RS, Zawacki JK, Curley FJ, French CL, Hoffman PJ: Chronic cough as the sole presenting manifestation of gastroesophageal reflux. Am Rev Respir Dis. 1989, 140 (5): 1294-1300.CrossRefPubMed Irwin RS, Zawacki JK, Curley FJ, French CL, Hoffman PJ: Chronic cough as the sole presenting manifestation of gastroesophageal reflux. Am Rev Respir Dis. 1989, 140 (5): 1294-1300.CrossRefPubMed
16.
go back to reference Kiljander TO, Salomaa ER, Hietanen EK, Terho EO: Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. Eur Respir J. 2000, 16 (4): 633-638. 10.1034/j.1399-3003.2000.16d11.x.CrossRefPubMed Kiljander TO, Salomaa ER, Hietanen EK, Terho EO: Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. Eur Respir J. 2000, 16 (4): 633-638. 10.1034/j.1399-3003.2000.16d11.x.CrossRefPubMed
17.
go back to reference Ing AJ, Breslin AB: The patient with chronic cough. Med J Aust. 1997, 166 (9): 491-496.PubMed Ing AJ, Breslin AB: The patient with chronic cough. Med J Aust. 1997, 166 (9): 491-496.PubMed
Metadata
Title
Prevalence and clinical manifestations of gastro-oesophageal reflux-associated chronic cough in the Japanese population
Authors
Hisako Matsumoto
Akio Niimi
Masaya Takemura
Tetsuya Ueda
Masafumi Yamaguchi
Hirofumi Matsuoka
Makiko Jinnai
Kazuo Chin
Michiaki Mishima
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Cough / Issue 1/2007
Electronic ISSN: 1745-9974
DOI
https://doi.org/10.1186/1745-9974-3-1

Other articles of this Issue 1/2007

Cough 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.